Bioorganic and Medicinal Chemistry p. 4364 - 4374 (2015)
Update date:2022-07-29
Topics:
Wang, Lei
Hou, Xuben
Fu, Huansheng
Pan, Xiaole
Xu, Wenfang
Tang, Weiping
Fang, Hao
Inhibition of HDACs activity has become a promising therapeutic strategy in clinical practice to reverse the abnormal epigenetic states of cancer and other diseases. Therefore, HDAC inhibitors become a relatively new class of anti-cancer agent. In the present study, we reported the design and synthesis of a series of novel HDAC inhibitors using various substituted quinoline rings as the cap group. In vitro studies showed that some compounds have good inhibitory activities against HDACs and potent antiproliferative activities in some tumor cell lines. Especially, compound 9w (IC50 = 85 nM), exhibited better inhibitory effect compared with SAHA (IC50 = 161 nM).
View MoreNanjing Fubang Chemical Co.,Ltd
Contact:+86-25-83179199
Address:5F,Tianzheng international plaza,No399 Zhongyang Road ,Nanjing China
Shanghai Longjin Metallic Material Co., Ltd.
website:http://www.shlongjin.cn/
Contact:021-56517503,56502257
Address:No.16, Lane 555, Chengyin Road, Shanghai
Ji'nan Orgachem Pharmaceutical Co.,Ltd
Contact:+86-531-82687810
Address:Jinan
Anhui Xinyuan Technology Co.,Ltd
website:http://www.ahxytech.com/
Contact:0086-559-3515800
Address:Huangshan City of Anhui Province Huizhou Huizhou District Road, 21-9
Nanjing Habo Medical Technology Co., Ltd.
Contact:025-85769882
Address:No.108. Ganjiabian east. Qixia District .Nanjing
Doi:10.1134/S1070363218070101
(2018)Doi:10.1021/ja804838y
(2008)Doi:10.1055/s-1991-26371
(1991)Doi:10.1021/jm00386a005
(1987)Doi:10.1021/om00145a004
(1987)Doi:10.1016/j.tetlet.2008.06.107
(2008)